GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sequent Scientific Ltd (NSE:SEQUENT) » Definitions » Gross-Profit-to-Asset %

Sequent Scientific (NSE:SEQUENT) Gross-Profit-to-Asset % : 48.21% (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Sequent Scientific Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Sequent Scientific's annualized Gross Profit for the quarter that ended in Dec. 2024 was ₹7,531 Mil. Sequent Scientific's average Total Assets over the quarter that ended in Dec. 2024 was ₹15,621 Mil. Therefore, Sequent Scientific's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 48.21%.


Sequent Scientific Gross-Profit-to-Asset % Historical Data

The historical data trend for Sequent Scientific's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequent Scientific Gross-Profit-to-Asset % Chart

Sequent Scientific Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.63 43.11 39.79 34.88 36.04

Sequent Scientific Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.64 28.53 45.68 44.39 48.21

Competitive Comparison of Sequent Scientific's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Sequent Scientific's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sequent Scientific's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sequent Scientific's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Sequent Scientific's Gross-Profit-to-Asset % falls into.



Sequent Scientific Gross-Profit-to-Asset % Calculation

Sequent Scientific's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=5531.85/( (15291.23+15403.84)/ 2 )
=5531.85/15347.535
=36.04 %

Sequent Scientific's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=7531.2/( (15620.5+0)/ 1 )
=7531.2/15620.5
=48.21 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Sequent Scientific Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Sequent Scientific's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sequent Scientific Business Description

Traded in Other Exchanges
Address
Plot No. E7, Road No. 22, 301, 3rd Floor, Dosti Pinnacle, Wagle Industrial Estate, Thane (West), Mumbai, MH, IND, 400 604
Sequent Scientific Ltd is a pharmaceutical company operating animal health and analytical services. It develops API products and formulations. The company's product portfolio includes products across various therapy classes such as antibiotics, anthelmintics, pain management, and nutrition. The company's geographical segment includes Europe, Asia, and Rest of the world. It generates maximum revenue from Europe.

Sequent Scientific Headlines

No Headlines